ClinicalTrials.Veeva

Menu

Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia"

A

Autonomous Non-Profit Organization National Society of Onco-Pulmonologists

Status

Unknown

Conditions

Stage III Non-small Cell Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

In connection with the transition to the 8th version of the classification of lung cancer according to the TNM system, there are currently no precise epidemiological data on stage III NSCLC, clinical characteristics of patients in this group, approaches to therapy and treatment results in the Russian Federation. The published statistics only provide information on the overall incidence of stage III lung, trachea and bronchial cancer, which is about 40%. This observational study will make it possible to characterize the Russian population of stage III non-small cell lung cancer patients, approaches to choosing a treatment option for stage III NSCLC and the outcomes of this treatment in real clinical practice.

Enrollment

1 estimated patient

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stage III non-small cell lung cancer

Exclusion criteria

  • the rest of the disease stage

Trial contacts and locations

1

Loading...

Central trial contact

Valeriy Breder, Leading Researcher; Konstantin Laktionov, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems